ACM
GILD icon

Altrius Capital Management’s Gilead Sciences GILD Stock Holding History

Altrius Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.32M Sell
45,311
-1,434
-3% -$201K 1.26% 38
2025
Q4 		$5.74M Sell
46,745
-1,373
-3% -$167K 1.22% 34
2025
Q3 		$5.34M Buy
48,118
+192
+0.4% +$21.8K 1.22% 37
2025
Q2 		$5.31M Buy
47,926
+154
+0.3% +$16.4K 1.24% 36
2025
Q1 		$5.35M Buy
47,772
+370
+0.8% +$38.2K 1.3% 34
2024
Q4 		$4.38M Sell
47,402
-15,005
-24% -$1.35M 1.18% 46
2024
Q3 		$5.23M Sell
62,407
-1,805
-3% -$138K 1.31% 32
2024
Q2 		$4.41M Buy
64,212
+11,232
+21% +$750K 1.16% 48
2024
Q1 		$3.88M Buy
52,980
+6,060
+13% +$466K 0.98% 64
2023
Q4 		$3.8M Buy
46,920
+58
+0.1% +$4.51K 1.06% 49
2023
Q3 		$3.51M Buy
46,862
+728
+2% +$56K 1.04% 44
2023
Q2 		$3.56M Buy
46,134
+200
+0.4% +$16K 1.05% 42
2023
Q1 		$3.81M Buy
45,934
+323
+0.7% +$26.8K 1.17% 30
2022
Q4 		$3.92M Sell
45,611
-1,457
-3% -$115K 1.23% 28
2022
Q3 		$2.9M Sell
47,068
-18,325
-28% -$1.16M 1.11% 43
2022
Q2 		$4.04M Buy
+65,393
New +$4.05M 1.31% 38

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Altrius Capital Management's GILD Position: Q1 2026 in Review

Altrius Capital Management reduced its Gilead Sciences (GILD) stake by 3.1% in Q1 2026, selling an estimated $201K and leaving 45,311 shares worth $6.32M. The position accounts for 1.26% of the portfolio, ranked #38.

Altrius Capital Management first reported a position in GILD in Q2 2022 and has held it in 16 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Altrius Capital Management held 45,311 shares of Gilead Sciences worth $6.32M as of Q1 2026.
  • Altrius Capital Management sold 1,434 Gilead Sciences shares in Q1 2026, an estimated $201K.
  • Gilead Sciences made up 1.26% of Altrius Capital Management's portfolio in Q1 2026, its #38 holding.
  • Altrius Capital Management first reported a position in Gilead Sciences in Q2 2022 and has held it in 16 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Altrius Capital Management's 13F filing for Q1 2026, filed 5 May 2026.